Anti-Body Drug Conjugates (ADCs)
Download brochure
If your language is not on the list, please contact us directly or advise your local association to become ENGAGe members.
Almost all modern cancer treatments aim to kill tumour cells while preserving healthy tissue. For gynaecological cancers (such as of the ovary, fallopian tube, peritoneum, cervix or endometrium), we now have a new class of medicines: antibody-drug conjugates (ADCs).
Suggested brochures
Ovarian Cancer
Ovarian cancer is a serious, life-threatening disease and is the seventh most commonly diagnosed cancer in women worldwide. In Europe, ovarian cancer is the sixth most common cancer among women with over 65 000 cases in 2012. The high mortality associated with ovarian cancer is due to the fact that it is often diagnosed at an advanced staged, by which time the patient has a poor prognosis.
Genetic Testing for Women with Cancer Predisposing Genes
Gynaecological cancers are those which affect the womb, ovaries, cervix, vulva or vagina. There are many different types of these cancers. Most occur by chance and are not inherited. A small number are caused by faults in our genetic material, which may be passed down through families. the purpose of this brochure is to shed more light on gene mutations, genetic testing, its advantages and potential disadvantages and implications of genetic testing for individual cancers.